My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid.

    Mora-García Mde L, Duenas-González A, Hernández-Montes J, De la Cruz-Hernández E, Pérez-Cárdenas E, Weiss-Steider B, Santiago-Osorio E, Ortíz-Navarrete VF, Rosales VH, Cantú D, Lizano-Soberón M, Rojo-Aguilar MP, Monroy-García A.

    J Transl Med. 2006 Dec 27;4:55.PMID: 17192185 [PubMed]Related articlesFree article

    2.

    The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.

    de la Cruz-Hernández E, Pérez-Cárdenas E, Contreras-Paredes A, Cantú D, Mohar A, Lizano M, Dueñas-González A.

    Virol J. 2007 Feb 26;4:18.PMID: 17324262 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.

    de Boer MA, Jordanova ES, van Poelgeest MI, van den Akker BE, van der Burg SH, Kenter GG, Fleuren GJ.

    Int J Cancer. 2007 Dec 15;121(12):2711-5.PMID: 17724722 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.

    Chavez-Blanco A, Perez-Plasencia C, Perez-Cardenas E, Carrasco-Legleu C, Rangel-Lopez E, Segura-Pacheco B, Taja-Chayeb L, Trejo-Becerril C, Gonzalez-Fierro A, Candelaria M, Cabrera G, Duenas-Gonzalez A.

    Cancer Cell Int. 2006 Jan 31;6:2.PMID: 16448574 [PubMed]Related articlesFree article

    5.

    Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.

    Song Y, Zhang C.

    Cancer Chemother Pharmacol. 2009 Mar;63(4):605-13. Epub 2008 Jun 3.PMID: 18521605 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell]

    Meng YS, Ma XX, Meng XQ, Wei R, Liu W, Ai GW, Zhang YX.

    Zhonghua Yi Xue Za Zhi. 2007 Dec 25;87(48):3406-10. Chinese. PMID: 18476539 [PubMed - indexed for MEDLINE]Related articles

    7.

    Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.

    Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.

    Br J Dermatol. 2008 May;158(5):930-40. Epub 2008 Feb 16.PMID: 18284388 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.

    Ye Q, Shen Y, Wang X, Yang J, Miao F, Shen C, Zhang J.

    Tissue Antigens. 2010 Jan;75(1):30-9. Epub 2009 Oct 30.PMID: 19883394 [PubMed - in process]Related articles

    9.

    Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.

    Rodríguez T, Méndez R, Del Campo A, Jiménez P, Aptsiauri N, Garrido F, Ruiz-Cabello F.

    BMC Cancer. 2007 Feb 23;7:34.PMID: 17319941 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.

    Li W, Deng XM, Wang CX, Zhang X, Zheng GX, Zhang J, Feng JB.

    Int J Gynecol Cancer. 2010 Feb;20(2):227-32.PMID: 20134267 [PubMed - in process]Related articles

    11.

    Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.

    Liu DW, Yang YC, Lin HF, Lin MF, Cheng YW, Chu CC, Tsao YP, Chen SL.

    J Virol. 2007 Mar;81(6):2869-79. Epub 2007 Jan 3.PMID: 17202211 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.

    Berghuis D, de Hooge AS, Santos SJ, Horst D, Wiertz EJ, van Eggermond MC, van den Elsen PJ, Taminiau AH, Ottaviano L, Schaefer KL, Dirksen U, Hooijberg E, Mulder A, Melief CJ, Egeler RM, Schilham MW, Jordanova ES, Hogendoorn PC, Lankester AC.

    J Pathol. 2009 Jun;218(2):222-31.PMID: 19274709 [PubMed - indexed for MEDLINE]Related articles

    13.

    Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

    Fonsatti E, Nicolay HJ, Sigalotti L, Calabrò L, Pezzani L, Colizzi F, Altomonte M, Guidoboni M, Marincola FM, Maio M.

    Clin Cancer Res. 2007 Jun 1;13(11):3333-8.PMID: 17545540 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.

    Xu Y, Zhu KJ, Chen XZ, Zhao KJ, Lu ZM, Cheng H.

    Arch Dermatol Res. 2008 Jun;300(5):235-42. Epub 2008 Feb 26.PMID: 18299861 [PubMed - indexed for MEDLINE]Related articles

    15.

    Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.

    Ivanova TA, Golovina DA, Zavalishina LE, Volgareva GM, Katargin AN, Andreeva YY, Frank GA, Kisseljov FL, Kisseljova NP.

    BMC Cancer. 2007 Mar 14;7:47.PMID: 17359536 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Modulation of HLA-G expression.

    Polakova K, Bandzuchova E, Tirpakova J, Kuba D, Russ G.

    Neoplasma. 2007;54(6):455-62.PMID: 17949227 [PubMed - indexed for MEDLINE]Related articles

    17.

    NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.

    Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A.

    Blood. 2008 Feb 1;111(3):1428-36. Epub 2007 Nov 9.PMID: 17993609 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.

    Manning J, Indrova M, Lubyova B, Pribylova H, Bieblova J, Hejnar J, Simova J, Jandlova T, Bubenik J, Reinis M.

    Immunology. 2008 Feb;123(2):218-27. Epub 2007 Aug 28.PMID: 17725605 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.

    Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto T.

    J Urol. 2007 Aug;178(2):692-6. Epub 2007 Jun 15.PMID: 17574613 [PubMed - indexed for MEDLINE]Related articles

    20.

    Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.

    Khan AN, Gregorie CJ, Tomasi TB.

    Cancer Immunol Immunother. 2008 May;57(5):647-54. Epub 2007 Nov 28.PMID: 18046553 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk